Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Omeros forms partnership for treatment of movement disorders
Under the collaboration, Omeros and The Parkinson’s Institute will conduct laboratory studies of one or more compounds that block Omeros’s proprietary target in a widely used and highly
Under the collaboration, Omeros and The Parkinson’s Institute will conduct laboratory studies of one or more compounds that block Omeros’s proprietary target in a widely used and highly
The new drug application provides for the use of Abacavir sulfate 60mg tablets in combination with other antiretrovirals for use in pediatric patients for the treatment of HIV-1
Vertex intends to grant the underwriters an option to purchase up to an additional 1.05 million shares of its common stock. Goldman, Sachs & Co is acting as
This designation, following potential marketing approval in the future will give Vivendy seven years of market exclusivity and could facilitate the recovery of certain regulatory filing fees. Vivendy’s
Subsequently, Biovail, the Canadian pharmaceutical company, has acquired Prestwick. Under the terms of the agreement, Biovail and Ovation will jointly develop additional follow-on indications for Xenazine and related
With completion of the acquisition, full integration of the companies is well underway. All 30 employees of Lipomics will become part of Tethys. Steven Watkins, co-founder, president and
The original filing contained claims related to both diagnostics and therapeutics. During the reviewing process, the mixed nature of the claims resulted in a split (technically known as
The hepatitis C virus (HCV) treated patients were among end-stage renal disease patients enrolled in human safety studies being conducted at the Fortis Hospital, in Delhi, India. In
These first Phase I trials for SB1518 comprise of ascending dose studies conducted at several leading clinical sites in the US. The trials are expected to enroll up
TussiCaps, which is approved by the FDA, is now available by prescription in 10mg/8mg capsules through wholesalers and pharmacies in the US. TussiCaps extended-release capsules are indicated for